NASDAQ:ESLA Estrella Immunopharma (ESLA) Stock Price, News & Analysis $0.97 -0.03 (-3.20%) (As of 04:27 PM ET) Add Compare Share Share Today's Range$0.88▼$1.0450-Day Range$1.00▼$2.2152-Week Range$0.81▼$20.80Volume37,444 shsAverage Volume52,881 shsMarket Capitalization$35.22 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Estrella Immunopharma alerts: Email Address Ad Porter & CompanyTrump’s weapon lurks in abandoned AmericaWhoever wins the presidential election – Trump or Harris – this energy surprise could see their popularity skyrocket… as a new period of wealth and prosperity sweeps across the nation… emanating from the last place anyone could have predicted. Now, billions of dollars are amassing behind this force, with everyone from Jeff Bezos and Bill Gates to Sam Altman and Warren Buffett pouring their money into this phenomenon.To find out more about this American resurrection, go here now to watch my new documentary About Estrella ImmunopharmaEstrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.Read More ESLA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ESLA Stock News HeadlinesAugust 24, 2024 | uk.finance.yahoo.comEstrella Immunopharma, Inc. (ESLAW)May 20, 2024 | investorplace.comESLA Stock Earnings: Estrella Immunopharma Reported Results for Q3 2024September 11, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaWhoever wins the presidential election – Trump or Harris – this energy surprise could see their popularity skyrocket… as a new period of wealth and prosperity sweeps across the nation… emanating from the last place anyone could have predicted. Now, billions of dollars are amassing behind this force, with everyone from Jeff Bezos and Bill Gates to Sam Altman and Warren Buffett pouring their money into this phenomenon.March 7, 2024 | finance.yahoo.comEntheon Biomedical Corp. (ENTBD)February 1, 2024 | msn.comEstrella Immunopharma Approves $1 Million Stock Buyback ProgramJanuary 17, 2024 | msn.comWhy DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving PremarketNovember 23, 2023 | uk.investing.comEstrella Immunopharma Inc (ESLA)November 3, 2023 | finance.yahoo.comEstrella Immunopharma, Inc. (ESLA)September 11, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaWhoever wins the presidential election – Trump or Harris – this energy surprise could see their popularity skyrocket… as a new period of wealth and prosperity sweeps across the nation… emanating from the last place anyone could have predicted. Now, billions of dollars are amassing behind this force, with everyone from Jeff Bezos and Bill Gates to Sam Altman and Warren Buffett pouring their money into this phenomenon.November 1, 2023 | morningstar.comEstrella Immunopharma Inc ESLAOctober 20, 2023 | finance.yahoo.comWe Think Estrella Immunopharma (NASDAQ:ESLA) Can Afford To Drive Business GrowthSee More Headlines Receive ESLA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/11/2024Next Earnings (Estimated)9/17/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ESLA CUSIPN/A CIK1844417 Webwww.estrellabio.com Phone510-318-9098FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-80,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-151.17% Return on Assets-26.43% Debt Debt-to-Equity RatioN/A Current Ratio62.34 Quick Ratio62.34 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($8.27) per share Price / Book-0.12Miscellaneous Outstanding Shares36,380,000Free Float16,333,000Market Cap$36.38 million OptionableNot Optionable Beta0.19 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Cheng Liu Ph.D. (Age 57)CEO, President & Director Jiandong XuChief Financial OfficerKey CompetitorsZura BioNASDAQ:ZURAVaxartNASDAQ:VXRTActuate TherapeuticsNASDAQ:ACTUMediWoundNASDAQ:MDWDFitLife BrandsNASDAQ:FTLFView All Competitors ESLA Stock Analysis - Frequently Asked Questions How have ESLA shares performed this year? Estrella Immunopharma's stock was trading at $1.11 on January 1st, 2024. Since then, ESLA stock has decreased by 12.8% and is now trading at $0.9680. View the best growth stocks for 2024 here. How do I buy shares of Estrella Immunopharma? Shares of ESLA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ESLA) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersPreferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stockThis company, known for its autonomous robotic surgical systems, completed a crowd-funded public offering and ...Deal Maker | SponsoredThe #1 Altcoin for September 2024With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviat...Market JAR | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredNatural is heading to the NasdaqNatural solutions are already better for the environment. But there’s one company taking it a step further: Th...MedX | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredThe $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ESLA Stock Alerts